Category:
Description:
Indications:
-
Depression
-
Chronic
pain (chronic tension headache, migraine, diabetic neuropathy, cancer
pain, postherpetic neuralgia)
Contraindications:
Precautions:
-
Pregnancy
category D; excreted into breast milk; effect on nursing infant
unknown
-
Suicidal
patients, convulsive disorders, prostatic hypertrophy, psychiatric
disease, sever depression, increased intra-ocular pressure,
narrow-angle glaucoma, urinary retention, hepatic/renal disease,
hyperthyroidism, elderly, abrupt discontinuation
Adverse
Reactions (Side Effects):
-
CNS:
anxiety, confusion, dizziness, drowsiness, exra-pyridimal symptoms,
insomnia, memory impairment, nervousness, nightmares, panic,
stimulation, tremors, weakness
-
CV:
dysrhythmias, hypertension, orthostatic hypotension, palpitations,
syncope, tachycardia
-
EENT:
blurred vision, mydriasis, nasal congestion, ophthalmoplegia, tinnitis
-
GI:
constipation, cramps, diarrhea, dry mouth, epigastric distress,
hepatitis, increased appetite, jaundice, nausea, paralytic ileus,
stomatitis, vomiting, weight gain
-
HEME:
agranulocytosis, eosinophilia, leukopenia, thrombocytopenia
-
GU:
urinary retention
-
SKIN:
photosensitivity, pruritis, rash, sweating, urticaria
|
Dosage:
Administered
orally (tablet) and intramuscularly (NEVER intravenously!)
-
Adult
dose:
-
PO
50-100mg at bedtime,
-
may
increase to 200mg daily, not to exceed 300mg daily (chronic pain
doses usually at lower end of range)
-
IM
(do not administer IV) 20-30mg four times daily, or
80-120mg at bedtime
-
Adolescent/geriatric:
-
Child
dose:
-
chronic
pain management:
-
depression:
Drug
interactions:
Numerous,
most significantly:
|
Source:
Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington,
D.C., 20372-5300
|